Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment of neuromyelitis optica.
An overview of pregnancy-related issues in patients with multiple sclerosis.
Sequence of Molecular Events during the Maturation of the Developing Mouse Prefrontal Cortex.
Multiple Sclerosis: Methods and Protocols. Preface.
Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT.
Fatigue in multiple sclerosis: a look at the role of poor sleep.
The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod.
Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes.
Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region.
Neurology of pregnancy.
Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein.
IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis.
Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, chol
Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging.
A urological challenge: Voiding dysfunction in multiple sclerosis.
Medical management of fecal incontinence in challenging populations: a review.
7(th) International Immunoglobulin Conference: Interlaken Leadership Awards.
Elevated In Vivo Levels of a Single Transcription Factor Directly Convert Satellite Glia into Oligodendrocyte-like Cells.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
Chronic stress regulates NG2(+) cell maturation and myelination in the prefrontal cortex through induction of death receptor 6.
Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.
TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress.
IL7Rα Expression and Upregulation by IFNβ in Dendritic Cell Subsets Is Haplotype-Dependent.
A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
Pages
« first
‹ previous
…
653
654
655
656
657
658
659
660
661
…
next ›
last »